Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mann, M.
Right arrow Articles by ZuWallack, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mann, M.
Right arrow Articles by ZuWallack, R. L.

Chest, Vol 101, 496-499, Copyright © 1992 by American College of Chest Physicians

ARTICLES

A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide

M Mann, O Eliasson, K Patel and RL ZuWallack
Section on Pulmonary Diseases, Saint Francis Hospital and Medical Center, Hartford, CT.

Noncompliance with inhaled steroids is a well-recognized problem in asthma therapy. We compared compliance with bid and qid regimens of inhaled flunisolide in 16 asthmatic subjects. Patients were instructed to take four inhalations bid for T1 to establish baseline compliance. During T2, half (group A) continued this dosing regimen, while the other half (group B) switched to two inhalations qid. Group A compliance did not significantly change from T1 to T2. The percentage of days with less than eight inhalations (underuse) for group B, however, increased from 20.2 +/- 40.3 in T1 (bid dosing) to 57.1 +/- 49.6 in T2 (qid dosing) (p less than 0.001). Concomitantly, the number of daily inhalations decreased from 7.9 +/- 2.5 to 6.8 +/- 3.1 (p less than 0.01). Reduced compliance with qid dosing was due in large part to an increase in frequency of six inhalations per day, resulting from tid use. Compliance with inhaled flunisolide, therefore, was worse with qid than bid dosing.


This article has been cited by other articles:


Home page
 ChestHome page
M. E. Purucker, C. J. Rosebraugh, F. Zhou, and R. J. Meyer
Inhaled Fluticasone Propionate by Diskus in the Treatment of Asthma: A Comparison of the Efficacy of the Same Nominal Dose Given Either Once or Twice a Day
Chest, October 1, 2003; 124(4): 1584 - 1593.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
K. R. Murphy, S. Fitzpatrick, M. Cruz-Rivera, C. J. Miller, and B. Parasuraman
Effects of Budesonide Inhalation Suspension Compared With Cromolyn Sodium Nebulizer Solution on Health Status and Caregiver Quality of Life in Childhood Asthma
Pediatrics, September 1, 2003; 112(3): e212 - 219.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. A. Nathan, J. T. C. Li, A. Finn, R. Jones, J. E. Payne, J. P. Wolford, and S. M. Harding
A Dose-Ranging Study of Fluticasone Propionate Administered Once Daily via Multidose Powder Inhaler to Patients With Moderate Asthma
Chest, August 1, 2000; 118(2): 296 - 302.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. ZuWallack, J. Adelglass, D. P. Clifford, S. P. Duke, P. D. Wire, M. Faris, and S. M. Harding
Long-term Efficacy and Safety of Fluticasone Propionate Powder Administered Once or Twice Daily via Inhaler to Patients With Moderate Asthma
Chest, August 1, 2000; 118(2): 303 - 312.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. J. APTER, S. T. REISINE, G. AFFLECK, E. BARROWS, and R. L. ZUWALLACK
Adherence with Twice-daily Dosing of Inhaled Steroids . Socioeconomic and Health-belief Differences
Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1810 - 1817.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. Weiner, M. Abramson, R. Puy, J. Wilson, J. M. Portnoy, I. Finegold, T. A.E. Platts-Mills, J. S. Klein, F. Chmelik, A. Doughty, et al.
Ragweed Immunotherapy in Adult Asthma
N. Engl. J. Med., July 18, 1996; 335(3): 203 - 206.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American College of Chest Physicians.